Canada's genetic heterogeneity an asset in cord blood banking

Silversides, Ann
June 2009
CMAJ: Canadian Medical Association Journal;6/23/2009, Vol. 180 Issue 13, pE117
Academic Journal
The article explores the significance of the proposed national public cord blood bank in Canada. Physician Clayton Smith, relates that this cord blood bank would provide the opportunity to contribute and to look at the missing donor types. Moreover, Sue Smith, executive director at OneMatch, pertains that private cord blood banking is controversial due to the absence of an identified recipient that would be difficult for finding a suitable matched unrelated donor.


Related Articles

  • Gift of life from a newborn babe. Franklin, Deborah; Lehrman, Sally // Health (Time Inc. Health);Oct96, Vol. 10 Issue 6, p15 

    Reports on a study at Duke University which found that only a few ounces of blood cells from the placenta of a healthy baby may be the best last hope for people with leukemia and other diseases treated by bone marrow transplants. Advantages of cord blood over the traditional bone marrow transplant.

  • Saving your newborn's valuable blood. DiPier, Lynn // Good Housekeeping;Jan97, Vol. 224 Issue 1, p114 

    Provides information on the blood from a newborn's umbilical cord that creates potential for saving many lives. Uses of cord blood; Laws passed by the US Food and Drug Administration (FDA) for cord-blood treatments; Medical centers where you can donate cord blood free.

  • Feasibility of umbilical cord blood transplantation with a myeloablative, reduced toxicity-conditioning regimen. Nishimoto, M; Nakamae, H; Nakamae, M; Hirose, A; Hagihara, K; Koh, H; Nakane, T; Terada, Y; Hino, M // Bone Marrow Transplantation;Jul2014, Vol. 49 Issue 7, p980 

    A letter to the editor is presented regarding umbilical cord blood transplantation (UCBT) with a myeloablative, reduced toxicity-conditioning strategy in older patients with comorbidities who have unrelated or not suitable related donors.

  • Seizing nature's lifeline. Kalb, Claudia; Beck, Melinda // Newsweek;4/29/1996, Vol. 127 Issue 18, p75 

    Researches the use of umbilical cord blood to treat leukemia and other diseases and conditions. The story of Paulette Lebed who has lymphocytic leukemia and will rely on blood from her newborn sister's cord; Umbilical cord, as a rich source of stem cells; Attempts by private firms to have...

  • Immunological reconstitution after cord blood transplantation for an adult patient. Nagayama, H; Nakayama, K; Yasuo, K; Tajika, K; Dan, K; Yamashita, N; Asano, S; Takahashi, T A // Bone Marrow Transplantation;7/15/99, Vol. 24 Issue 2, p211 

    We transplanted 4.1 × 107 unrelated umbilical cord blood cells into a 27-year-old patient suffering from transformed acute myelocytic leukemia. The thawing method was the same as described by Rubinstein et al (Proc Natl Acad Sci USA 1995; 92: 10119–10122). ANC reached over 500 ×...

  • First state license to retain cord blood for transplant issued in New Jersey. Zacharia, Mark // MLO: Medical Laboratory Observer;Feb97, Vol. 29 Issue 2, p8 

    Reports the issuance of license to the Coriell Institute for Medical Research in Camden, New Jersey to collect and store the cord blood of newborns for therapeutic transplant. Storage fee; Therapeutic effects of the stored cord blood; Documentation of procedures.

  • Is in vitro expansion of human cord blood cells clinically relevant? Denning-Kendall, P A; Nicol, A; Horsley, H; Donaldson, C; Bradley, B; Hows, J M // Bone Marrow Transplantation;2/1/98, Vol. 21 Issue 3, p225 

    Peripheral blood recovery after cord blood (CB) transplantation is delayed compared with marrow. Expansion of CB haemopoietic cells has been investigated with the aim of reducing cytopenia following transplantation. Mature cells, post-progenitors, progenitors and long-term culture-initiating...

  • In situ chimerism after double cord blood transplantation. Labussière, H; Loiseau, P; Clave, E; Janin, A; Socié, G // Bone Marrow Transplantation;Dec2013, Vol. 48 Issue 12, p1582 

    A letter to the editor is presented on in situ chimerism after double cord blood transplantation.

  • KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation. Tarek, N; Gallagher, M M; Chou, J F; Lubin, M N; Heller, G; Barker, J N; Hsu, K C // Bone Marrow Transplantation;Jan2015, Vol. 50 Issue 1, p150 

    A letter to the editor is presented in response to the article KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation published in the October 1, 2014 issue of the journal Bone Marrow Transplantation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics